Counterfeit weight-loss pens — what UK users should know

The MHRA position

The Medicines and Healthcare products Regulatory Agency has issued public warnings about counterfeit and unlicensed weight-loss injection products in the UK. Genuine licensed medicines (Mounjaro, Wegovy, Saxenda) are supplied via UK-registered pharmacies on the authority of a UK prescriber following appropriate clinical assessment. Anything supplied outside that route may be counterfeit, mis-formulated, contaminated, mis-dosed or contain a different active ingredient.

Why counterfeit pens are dangerous

• The active ingredient may be incorrect, absent, or replaced with another substance.
• Dose accuracy may be unreliable, increasing both efficacy failure and adverse-event risk.
• Sterility cannot be assumed; injection-site infection risk is real.
• Pharmacovigilance and regulator-monitored adverse-event reporting do not apply.
• If something goes wrong there is no recall pathway, no batch traceability and no clinical oversight.

What this page deliberately does not include

We do not publish detailed counterfeit-identification methodology, packaging comparison images, supply-chain entry points or evasion-relevant detail. Counterfeit-detection content of that kind can be repurposed by counterfeiters to refine their products. Our role is to flag the risk, point readers to the MHRA and to qualified clinical care, not to teach counterfeiter craft.

What UK users should do if they suspect a counterfeit product

• Stop use and seek qualified clinical assessment — a UK prescriber, GP or NHS 111 in the first instance; A&E or 999 in an emergency.
• Report the suspected counterfeit medicine to the MHRA through the Yellow Card scheme (yellowcard.mhra.gov.uk) and to the relevant UK pharmacy regulator (GPhC) where supply involved an online pharmacy claiming UK regulation.
• Preserve the packaging, batch numbers, supplier correspondence and shipping details so the regulator has the information needed to investigate.
• Do not pass the product to another individual. Do not use a replacement sourced outside the licensed prescribing pathway.

The wider weight-loss-pen ecosystem

Counterfeit pens are one part of a broader unregulated-supply landscape that includes grey-market peptide vials and unauthorised compounded preparations. The risks overlap but are not identical. See the grey-market peptides and online pharmacy verification pages for more context.